Zydus Lifesciences Limited reported a 30 per cent year-on-year increase in net profit to ₹1,023.5 crore for the quarter ended December 31, 2024, driven by robust performance in its US ...

Zydus Lifesciences (ZYDUSLIF) Q3 adjusted EBITDA for one offs was below our estimate led by lower GMs and higher R&D spend. We believe the company’s steady domestic franchise, strong balance ...

Its revenue from operations stood at Rs 5,269, with a rise of 17 percent, compared to Rs 4,505 crore in Q3FY24. Zydus Lifesciences share prices were trading at over 2 percent gain during early ...

(Image Credits: Pixabay) Zydus Lifesciences Ltd on Wednesday reported a profit of Rs 1023.80 crore during the third quarter of FY25, posting a growth of 29.66 per cent in comparison to Rs 789.60 ...

Zydus Lifesciences Ltd share price was up by -1.05% from the previous closing price of ₹974.00. Who are peers of Zydus Lifesciences Ltd? The peers of Zydus Lifesciences Ltd are Sun ...

Zydus Wellness is engaged in the development, production, marketing and distribution of health and wellness products. It has 7 leading brands in its portfolio, namely Complan, Sugar Free ...

Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

For FMCG companies, rural India has become the new frontier. As consumption in rural areas grows at a faster pace than in urban markets, companies are ramping up their efforts to tap into this ...

Zydus Lifesciences Ltd. said on Wednesday that the US Food and Drug Administration granted its underdevelopment drug Usnoflast the orphan drug designation, according to an exchange filing on Wednesday ...

Zydus Lifesciences Q3 Earnings: Zydus Lifesciences reported a 30% YoY rise in Q3FY25 net profit to ₹1,023.5 crore, driven by strong US growth. Revenue increased 17% YoY, while EBITDA rose 26%. The ...